InvestorNewsBreaks – Predictive Oncology (NASDAQ: POAI) Closes on $7.2M in Registered Direct Offerings
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it has closed on two direct offerings. The offerings, which were available concurrently, were with different institutional investors and results in approximately $7.2 million in gross proceeds for the company, before the deduction of agent fees and other expenses. The first offering involved the…